Angioimmunoblastic T-Cell lymphoma: a diagnostic challenge

Angioimmunoblastic T-cell lymphoma (AITL) accounts for 15–20% of all peripheral T-cell lymphomas. It is a rare subtype of CD4 T-cell peripheral lymphoma that affects aged individuals, causing B symptoms, generalized lymphadenopathy and hepatosplenomegaly. Its pathogenesis is still unclear, but in so...

Descripción completa

Detalles Bibliográficos
Autores principales: Ocampo Garza, Jorge, Herz Ruelas, Maira Elizabeth, González Lopez, Elias Eugenio, Mendoza Oviedo, Eric Eduardo, Garza Chapa, Juana Irma, Ocampo Garza, Sonia Sofía, Vázquez Herrera, Norma Elizabeth, Miranda Maldonado, Ivett C., Ocampo Candiani, Jorge
Formato: Artículo
Lenguaje:inglés
Publicado: 2014
Materias:
Acceso en línea:http://eprints.uanl.mx/15235/1/337.pdf
_version_ 1824414294622601216
author Ocampo Garza, Jorge
Herz Ruelas, Maira Elizabeth
González Lopez, Elias Eugenio
Mendoza Oviedo, Eric Eduardo
Garza Chapa, Juana Irma
Ocampo Garza, Sonia Sofía
Vázquez Herrera, Norma Elizabeth
Miranda Maldonado, Ivett C.
Ocampo Candiani, Jorge
author_facet Ocampo Garza, Jorge
Herz Ruelas, Maira Elizabeth
González Lopez, Elias Eugenio
Mendoza Oviedo, Eric Eduardo
Garza Chapa, Juana Irma
Ocampo Garza, Sonia Sofía
Vázquez Herrera, Norma Elizabeth
Miranda Maldonado, Ivett C.
Ocampo Candiani, Jorge
author_sort Ocampo Garza, Jorge
collection Repositorio Institucional
description Angioimmunoblastic T-cell lymphoma (AITL) accounts for 15–20% of all peripheral T-cell lymphomas. It is a rare subtype of CD4 T-cell peripheral lymphoma that affects aged individuals, causing B symptoms, generalized lymphadenopathy and hepatosplenomegaly. Its pathogenesis is still unclear, but in some cases it has been associated with infection, allergic reaction or drug exposure. The majority of patients are diagnosed in an advanced stage and anthracycline based regimen is considered the first-line therapy. Skin involvement is not well characterized, occurring in up to 50% of patients and presenting as nonspecific rash, macules, papules, petechiae, purpura, nodules and urticaria. We present the illustrative case of a 55-year-old woman with an AITL who presented prominent skin findings, arthritis, lymphadenopathy and hypereosinophilia. Skin biopsy reported a T-cell lymphoma and the diagnosis of AITL was confirmed by an axillary lymph node biopsy, which was also positive for EpsteinBarr virus. Chemotherapy with CHOP-21 and thalidomide was given, accomplishing complete remission after six cycles.
format Article
id eprints-15235
institution UANL
language English
publishDate 2014
record_format eprints
spelling eprints-152352022-04-07T22:00:09Z http://eprints.uanl.mx/15235/ Angioimmunoblastic T-Cell lymphoma: a diagnostic challenge Ocampo Garza, Jorge Herz Ruelas, Maira Elizabeth González Lopez, Elias Eugenio Mendoza Oviedo, Eric Eduardo Garza Chapa, Juana Irma Ocampo Garza, Sonia Sofía Vázquez Herrera, Norma Elizabeth Miranda Maldonado, Ivett C. Ocampo Candiani, Jorge RL Dermatología Angioimmunoblastic T-cell lymphoma (AITL) accounts for 15–20% of all peripheral T-cell lymphomas. It is a rare subtype of CD4 T-cell peripheral lymphoma that affects aged individuals, causing B symptoms, generalized lymphadenopathy and hepatosplenomegaly. Its pathogenesis is still unclear, but in some cases it has been associated with infection, allergic reaction or drug exposure. The majority of patients are diagnosed in an advanced stage and anthracycline based regimen is considered the first-line therapy. Skin involvement is not well characterized, occurring in up to 50% of patients and presenting as nonspecific rash, macules, papules, petechiae, purpura, nodules and urticaria. We present the illustrative case of a 55-year-old woman with an AITL who presented prominent skin findings, arthritis, lymphadenopathy and hypereosinophilia. Skin biopsy reported a T-cell lymphoma and the diagnosis of AITL was confirmed by an axillary lymph node biopsy, which was also positive for EpsteinBarr virus. Chemotherapy with CHOP-21 and thalidomide was given, accomplishing complete remission after six cycles. 2014 Article PeerReviewed text en cc_by_nc_nd http://eprints.uanl.mx/15235/1/337.pdf http://eprints.uanl.mx/15235/1.haspreviewThumbnailVersion/337.pdf Ocampo Garza, Jorge y Herz Ruelas, Maira Elizabeth y González Lopez, Elias Eugenio y Mendoza Oviedo, Eric Eduardo y Garza Chapa, Juana Irma y Ocampo Garza, Sonia Sofía y Vázquez Herrera, Norma Elizabeth y Miranda Maldonado, Ivett C. y Ocampo Candiani, Jorge (2014) Angioimmunoblastic T-Cell lymphoma: a diagnostic challenge. Case reports in dermatology, 6 (3). pp. 291-295. ISSN 1662-6567 http://doi.org/10.1159/000370302 doi:10.1159/000370302
spellingShingle RL Dermatología
Ocampo Garza, Jorge
Herz Ruelas, Maira Elizabeth
González Lopez, Elias Eugenio
Mendoza Oviedo, Eric Eduardo
Garza Chapa, Juana Irma
Ocampo Garza, Sonia Sofía
Vázquez Herrera, Norma Elizabeth
Miranda Maldonado, Ivett C.
Ocampo Candiani, Jorge
Angioimmunoblastic T-Cell lymphoma: a diagnostic challenge
thumbnail https://rediab.uanl.mx/themes/sandal5/images/online.png
title Angioimmunoblastic T-Cell lymphoma: a diagnostic challenge
title_full Angioimmunoblastic T-Cell lymphoma: a diagnostic challenge
title_fullStr Angioimmunoblastic T-Cell lymphoma: a diagnostic challenge
title_full_unstemmed Angioimmunoblastic T-Cell lymphoma: a diagnostic challenge
title_short Angioimmunoblastic T-Cell lymphoma: a diagnostic challenge
title_sort angioimmunoblastic t cell lymphoma a diagnostic challenge
topic RL Dermatología
url http://eprints.uanl.mx/15235/1/337.pdf
work_keys_str_mv AT ocampogarzajorge angioimmunoblastictcelllymphomaadiagnosticchallenge
AT herzruelasmairaelizabeth angioimmunoblastictcelllymphomaadiagnosticchallenge
AT gonzalezlopezeliaseugenio angioimmunoblastictcelllymphomaadiagnosticchallenge
AT mendozaoviedoericeduardo angioimmunoblastictcelllymphomaadiagnosticchallenge
AT garzachapajuanairma angioimmunoblastictcelllymphomaadiagnosticchallenge
AT ocampogarzasoniasofia angioimmunoblastictcelllymphomaadiagnosticchallenge
AT vazquezherreranormaelizabeth angioimmunoblastictcelllymphomaadiagnosticchallenge
AT mirandamaldonadoivettc angioimmunoblastictcelllymphomaadiagnosticchallenge
AT ocampocandianijorge angioimmunoblastictcelllymphomaadiagnosticchallenge